Jefferies Financial Group’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Jefferies Financial Group’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-95,000	Closed	-$8.73K	–	2000
2023 Q3	$8.73K	Hold	95,000	–	–	﹤0.01%	1546
2023 Q2	$2.65K	Hold	95,000	–	–	﹤0.01%	1604
2023 Q1	$9.01K	Hold	95,000	–	–	﹤0.01%	1555
2022 Q4	$10.5K	Buy	+95,000	New	+$31K	﹤0.01%	1476

Other funds holding STLNW

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

Jefferies Financial Group's STLNW Position: Q4 2023 in Review

Jefferies Financial Group sold out of Starling Oncology, Inc. Warrant (STLNW) in Q4 2023, closing a stake of 95,000 shares — an estimated $8.73K sold.

Jefferies Financial Group first reported a position in STLNW in Q4 2022 and held it in 4 quarters. The position peaked at $10.5K in Q4 2022. 16 funds tracked by Wall St. Rank hold STLNW as of Q4 2023.

Jefferies Financial Group reported no remaining Starling Oncology, Inc. Warrant position as of Q4 2023 after selling out during the quarter.
Jefferies Financial Group sold 95,000 Starling Oncology, Inc. Warrant shares in Q4 2023, an estimated $8.73K.
Jefferies Financial Group first reported a position in Starling Oncology, Inc. Warrant in Q4 2022 and held it in 4 quarters.
Jefferies Financial Group's Starling Oncology, Inc. Warrant position peaked at $10.5K in Q4 2022.
16 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q4 2023.

Based on Jefferies Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.